On June 5, Trinity Biotech plc(ADR) (NASDAQ:TRIB) announced a annual dividend on Friday, May 23rd, StockRatingsNetwork.com reports. Stockholders of record on Tuesday, June 10th will be paid a dividend of 0.22 per share on Tuesday, July 1st. This represents a dividend yield of 3.72%. Trinity Biotech plc (ADR) (NASDAQ:TRIB) net profit margin is 10.90% and weekly performance is -2.31%. On last trading day company shares ended up $23.22. Analysts mean target price for the company is $33.25. Trinity Biotech plc (ADR) (NASDAQ:TRIB) distance from 50-day simple moving average (SMA50) is -1.57%.
Jun 4, 2014 – Quidel Corporation(NASDAQ:QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced that it will present at the Wells Fargo Securities 2014 Healthcare Conference to be held at the InterContinental Boston hotel in Boston, MA on Tuesday, June 17, 2014. Quidel Corporation (NASDAQ:QDEL) shares fell -1.30% in last trading session and ended the day on $2.70. Gross Margin is 55.70% and its return on assets is -2.50%. Quidel Corporation (NASDAQ:QDEL) quarterly performance is -19.76%.
On May 28, Meridian Bioscience, Inc. (NASDAQ:VIVO) announced that it has received medical device license approval from Health Canada to market two additional assays for use on their illumigene(R) molecular diagnostic platform. With the addition of illumigene Mycoplasma and illumigene Pertussis, Meridian continues to expand its position in the Canadian market by providing innovative testing solutions that meet the needs of the clinical laboratory and drive improvements in patient care. Meridian Bioscience, Inc. (NASDAQ:VIVO) shares moved down -0.05% in last trading session and was closed at $20.10, while trading in range of $19.94 – $20.27. Meridian Bioscience, Inc. (NASDAQ:VIVO) year to date (YTD) performance is -22.81%.
On June 13, Bitcoin Shop Inc (OTCMKTS:BTCS) has announced that its CEO, Charles Allen, will grace the Bitcoin in the Beltway 2014 conference as a panelist. The event will take place from June 20 – 22, at Marriott Renaissance Downtown, Washington D.C. Bitcoin Shop Inc (OTCMKTS:BTCS) ended the last trading day at $0.195.
May 15, 2014 — Vermillion, Inc. (NASDAQ:VRML) a multivariate diagnostics company focused on gynecologic cancers and women’s health, reported on its results for the quarter ended March 31, 2014. Total revenue in the first quarter of 2014 was $305,000, as compared to $328,000 in the same year-ago period. First quarter 2014 revenue was comprised of $191,000 in OVA1 product revenue and $114,000 in license revenue. Vermillion, Inc. (NASDAQ:VRML) weekly performance is 10.27%. On last trading day company shares ended up $2.90. Vermillion, Inc. (NASDAQ:VRML) distance from 50-day simple moving average (SMA50) is 0.15%.